Mustang Bio appoints James Murphy as Interim CFO effective Jan 19, 2024

MUSTANG BIO, INC.

James Murphy appointed Interim CFO, serving as Principal Financial and Accounting Officer.
Murphy provides consulting services via Danforth Advisors; receives no direct compensation from Mustang.
Murphy has served as interim CFO for public and private life science companies since 2012.
No family relationships or material transactions exist between Murphy and Mustang's officers or directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

James Murphy

Interim Chief Financial Officer

MBIO · MUSTANG BIO, INC.

Effective: 2024-01-19
Filed: January 25, 2024, 6:59 PM ET

On January 19, 2024, Mustang Bio, Inc. (the “Company”) appointed James Murphy as the Company’s Interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Murphy was appointed as Interim Chief Financial Officer at MUSTANG BIO, INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On January 19, 2024, Mustang Bio, Inc. (the “Company”) appointed James Murphy as the Company’s Interim Chief Financial Officer.

View on SEC.gov

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-006668

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.